34.11. Analysis.

Comparison 34 Oral retinoids: alitretinoin versus placebo, Outcome 11 Secondary: investigator‐rated reduction in severity in total lesion symptom score.

Secondary: investigator‐rated reduction in severity in total lesion symptom score
Study	Group	Median	SD	N
Alitretinoin 40 mg vs placebo
Ruzicka 2004	Alitretinoin 40 mg	70.5	81.407	81
Ruzicka 2004	Placebo	25.0	62.13	78
Alitretinoin 20 mg vs placebo
Ruzicka 2004	Alitretinoin 20 mg	52.0	80.9	80
Ruzicka 2004	Placebo	25.0	62.13	78
Alitretinoin 10 mg vs placebo
Ruzicka 2004	Alitretinoin 10 mg	59.0	89.892	80
Ruzicka 2004	Placebo	25.0	62.13	78